share_log

BioCryst Pharmaceuticals analyst ratings

Benzinga Analyst Ratings ·  Mar 24, 2021 19:37
DateResearch FirmActionCurrentPT
3/24/21HC Wainwright & Co.MaintainsBuy19.0
1/22/21RBC CapitalMaintainsSector Perform9.0
12/07/20HC Wainwright & Co.MaintainsBuy14.0
11/24/20Evercore ISI GroupInitiates Coverage OnOutperform12.0
6/17/20BTIGInitiates Coverage OnNeutral
5/05/20BarclaysUpgradesOverweight7.0
11/15/19Bank of AmericaUpgradesBuy
5/24/19RBC CapitalDowngradesSector Perform4.5
4/02/19BarclaysMaintainsEqual-Weight8.0
4/02/19JMP SecuritiesMaintainsMarket Outperform18.0
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment